bibliographicCitation |
BOTTENFIELD GW, BURCH DJ, HEDRICK JA, SCHATEN R, ROWINSKI CA, DAVIES JT. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin®) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. The Pediatric Infectious Disease Journal. 1998 Oct;17(10):963–8. doi: 10.1097/00006454-199810000-00041. |